Results 11 to 20 of about 14,935 (222)
The polo-like kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia [PDF]
, 2013 CD56 is expressed in 15–20% of acute myeloid leukaemias (AML) and is associated with extramedullary diffusion, multidrug resistance and poor prognosis.
A Blair +55 more
core +6 more sources
Pediatric acute lymphoblastic leukemia and leukapheresis: CT evidence of hemorrhagic complication
European Journal of Radiology Open, 2020 Leukapheresis has been used widely to quickly reduce white blood cell count (WBC) in patients with hyperleukocytosis. Despite its wide utilization, leukapheresis has risks of complication, which have not been thoroughly reported in pediatric patients. No
Benedicta Mutiara Suwita +1 more
doaj +1 more source
Global Journal of Transfusion Medicine, 2021 Therapeutic leukapheresis is performed in patients having hyperleukocytosis, leading to leukostasis. The aim of this study was to evaluate the efficacy of therapeutic leukapheresis in reducing white cell count in leukemic patients with symptoms of ...
Tapti Mohapatra, Prabodha Kumar Das
doaj +1 more source
Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment [PDF]
, 2020 Dendritic cells play a key role in activation of the immune system as potent antigen-presenting cells. This pivotal position, along with the ability to generate dendritic cells from monocytes and ready uptake of antigen, makes them an intriguing vehicle ...
Cox, Cheryl, Hopewell, Emily L.
core +1 more source
IJRETINA (International Journal of Retina), 2020 Introduction: to report a case of bilateral leukemic retinopathy due to leukostasis that was successfully managed by leukapheresis. Case Presentation: 31-year-old male with mild visual disturbance was referred to ophthalmology department.
Ruchyta Ranti +7 more
doaj +1 more source
Characteristics of autologous peripheral blood stem cells collection over a one-year period [PDF]
Medicinski Glasnik, 2020 Aim To present characteristics of collecting autologous peripheral blood stem cells over a one-year period with an emphasis on efficiency and safety. Methods A retrograde analysis of 24 leukapheresis in 20 adult patients with malignant haematological ...
Gorana Ahmetović-Karić +2 more
doaj +1 more source
Journal of Applied Hematology, 2021 INTRODUCTION: Peripheral blood stem cell has become the preferred source for hematopoietic stem cells in both autologous and allogenic transplants. CD34+ cells represent a small proportion of the leukapheresis product content.
Mohandoss Murugesan +3 more
doaj +1 more source
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients [PDF]
, 1997 Cell lymphomas which often contain the Epstein-Barr virus (EBV) make up the preponderance of tumors that collectively have been termed posttransplant lymphoproliferative disorders (PTLD).
Alard +14 more
core +2 more sources
Leukapheresis Therapy of Chronic Lymphocytic Leukemia [PDF]
Blood, 1972 Abstract The effects of repeated leukapheresis with the IBM Blood Cell Separator were assessed in 13 patients with chronic lymphocytic leukemia (CLL). Five patients had from 14 to 25 leukaphereses at intervals ranging from 7 to 33 days. The median total number of lymphocytes removed was 18.0 x 1011 (range 11.9 x 1011-26.6 x 1011). Two of
J E, Curtis, E M, Hersh, E J, Freireich
openaire +2 more sources
Toxics, 2022 Background: The treatment of relapsed or refractory leukemia remains a major problem. Among the new therapeutic approaches, the use of modified T lymphocytes, called chimeric antigen receptor T cells (CAR-T cells), seems promising.
Raphaëlle Lautraite +6 more
doaj +1 more source